About IEC

Jianling Du

Title: Professor
Email: dujianling63@163.com
Major: Internal Medicine

Education/Working Experience

1. Education Experience

Jan 2013-Apr 2013   The University of Chicago, Visiting Scholar

Mar 2003-Dec 2008  Dalian University of Technology, Doctor’s Degree

Sep 1995-Jun 1998   Dalian Medical University, Master’s Degree

Sep 1981-Jul 1986    Dalian Medical University, Bachelor’s Degree


2 . Working Experience

Jan 2012-present     First Affiliated Hospital of Dalian Medical University,

Director of Clinical Diagnostic Department

May 2001-present    First Affiliated Hospital of Dalian Medical University,

Associate Director and Executive Deputy Director of 

Internal Medicine Department respectively

Apr 2001-present     First Affiliated Hospital of Dalian Medical University, 

                             Director of Department of Endocrinology 

Oct 2003-present     First Affiliated Hospital of Dalian Medical University, 

Chief Physician/Professor

Oct 1998-Sep 2003   First Affiliated Hospital of Dalian Medical University,

Associate Chief Physician/Associate Professor

Jul 1993-Sep 1998    First Affiliated Hospital of Dalian Medical University,

                              Attending Doctor

Jul 1986-Jun 1993    First Affiliated Hospital of Dalian Medical University,

                              Resident Doctor


Participation in the Academic Community

1. Member of Chinese Society of Endocrinology

2. Chairman designate of Liaoning Diabetes Society

3. Chairman of Dalian Diabetes Society

4. Member of Chinese Endocrinologist Association

Publication


1. Yang Yu, Yao Jun-jie, Du Jian-ling*, Bai Ran, Sun Li-peng, Sun Guo-hua,

Song Gui-rong, Cao Si-ming, Shi Chun-hong, Ba Ying, Xing Qian, Zhang Xueyang. Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes mellitus by intensified multifactorial intervention-Seven-year follow-up of diabetes complications in Chinese. Diabetes Care, 2013, 36: 978-984. (SCI, IF 8.57)

2. Yin Zhao, Hua Li, Li-li Men, Rong-chong Huang, Hai-cheng Zhou, Qian Xing,

Jun-jie Yao, Chun-hong Shi, Jian-ling Du*. Effects of selenoprotein S on oxidative

injury in human endothelial cells. Journal of Translational Medicine, 2013, 11: 287-305. (SCI, IF 3.991)

3. Zhou Haicheng, Liu Jing, Ren Liyuan, Liu Wei, Xing Qian, Men Lili, Song Guirong, 
Du Jianling*. Relationship between spatial memory in diabetic rats and protein kinase Cγ, caveolin-1 in the hippocampus and neuroprotective effect of catalpol. Chin Med J, 2014, 127(5):916-23. (SCI, IF 1.016)
4. Qiu-Ming Wang,Du Jianling*,Zhi-Jun Duan,et al. Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation. World J Gastroenterol 2013,19(19): 2922-2935. (*Co-first author, SCI, IF 2.547)

5. DU Jian-ling, LIU Jian-feng, MEN Li-li, YAO Jun-jie, SUN Li-peng, SUN Guo-hua, SONG Gui-rong, YANG Yu, BAI Ran, XING Qian, LI Chang-chen and SUN Chang-kai. Effects of five-year intensive multifactorial intervention on the serum amyloid A and macroangiopathy in patients with short-duration type 2 diabetes mellitus. Chin Med J, 2009, 122(21):2560-2566. (SCI, IF 0.952)

6. DU Jian-Ling, SUN Chang-Kai, LÜ Bo, et al. Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus. Chin Med J, 2008, 121(13): 1165-1168. (SCI, IF 0.858)

7. DU Jian-Ling, AN Li-Jia, SUN Chang-Kai, et al. Overexpressing SelS may protect human umbilical vein endothelial cells from injuring by H2O2. Prog Biochem Biophys, 2007, 34(4): 425-430. (SCI, IF 0.214)

8. Min Hao, Shu-yuan Li, Chang-kai Sun, Jingyu-Xu, Yuan Lin, Ke-xin Liu, Li Wang, Chuan-xun Li, Qin Zhou, Jian-ling Du, Hua Li. Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro. Eur J Pharmacol, 2011, 645: 320-325.

(SCI, IF 2.737)

9. Qiu-Ming Wang, Zhi-Jun Duan, Jian-Ling Du, Shi-Bin Guo, Xiao-Yu Sun, Zhen Liu. Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy. International Journal of Molecular Medicine, 2013, 31: 1186-1194. (SCI, IF 1.957)


(*Corresponding author,  #Co-first author)



(*Corresponding author,  #Co-first author)

 

Research Projects/Grants

1. The Mechanism of Multifactorial Endothelial Injury and Antioxidant Protection of Selenoprotein S in Diabetic Vascular Endothelium-Mimicking Microenvironment

 (Supproted by National Natural Science Foundation of China, Grant No. 81570727, Jan 2016-Dec 2019, ¥520,000, Principal Investigator)

2. Application of iTRAQ Combined with 2D LC-MS/MS Filtering Serum Biomarkers and Serum Predictors in T2DM with Macroangiopathy

  (Supproted by National Natural Science Foundation of China, Grant No. 81300671, Jan 2014-Dec 2016, ¥230,000, Participant)

3. A Survey of National Thyroid Diseases and Iodine Nutritional Status

  (Supported by National Health and Family Planning Commission, Grant No. 201402005, Apr 2014-Jul 2016, ¥320,000, Sub-Project Principal Investigator)

4. The mechanism of multifactorial endothelial injury in diabetic vascular endothelium- mimicking microenvironment

  (Supported by Natural Science Foundation of Liaoning Province, Grant No.2015020290,

  Jul 2015-Jun 2017, ¥50,000, Principal Investigator)

5. Genomics, Proteomics and Metabonomics Analysis of Antithyroid Drug-Induced

Adverse Effects in Patients with Graves’ Disease

  (Supported by Science and Technology Department of Liaoning Province, Grant No.

 2012225020, Jan 2012-Dec 2014, ¥50,000, Principal Investigator)

6. Screening of Biomarkers Associated with Antithyroid Drug-Induced Adverse Effects

  (Supported by Dalian Municipal Science and Technology Bureau, Grant No.

2013E15SF161, Jan 2013-Dec 2015, ¥100,000, Principal Investigator)

Admission Plan/Requirements

Admission Plan:  One student/year

Requirements:   good oral English / Chinese, good writing English skill